Addressing the core challenges facing the microbiome industry, to translate academic research into clinically and commercially viable therapeutics.
Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they use in their daily lives.
UK-based life science investor Syncona has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown develop
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Join us in San Francisco, CA this April for LEAP HR: Life Sciences West to network with 200+ senior HR leaders
With recent expansion into autoimmune pipelines, the year of the ‘bounce back’ now feels in reach for the NK space.
